Cannabinoid and Psychedelic Pharmacology and Drug Development

Cannabinoid and Psychedelic Pharmacology and Drug Development

por Jim Mitchell and Google NotebookLM
QuímicaCiencias de la Vida
Temporada 4

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 25 Global Perspectives and Harmonization

This podcast episode explores global regulations for cannabis and psychedelic therapies, comparing approaches between the US FDA, Canada, and the EU. The discussion covers ICH guidelines for harmonizing drug development standards internationally, the role of botanical drug classifications, and the challenges of balancing innovation with accessibility. Key topics include mutagenic impurity guidelines, analytical procedures for quality control, and the integration of real-world data with clinical trial results.
T4 · E28
31 ene 2025
10:22

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 26 Advanced Topics in Process Chemistry and Scalability

This podcast episode explores the complex challenges of scaling up production of cannabinoid and psychedelic APIs (Active Pharmaceutical Ingredients) from laboratory to commercial scale. Using Watson's Pharmaceutical Process Development as a guide, the discussion covers key aspects including: - Balancing yield maximization, cost minimization, and waste management while maintaining product safety and efficacy - The differences between batch and continuous processing methods - Specific challenges with sensitive compounds from natural sources, including quality control and contamination prevention - Environmental considerations and sustainable production methods, including green chemistry approaches The episode provides detailed insights into both traditional extraction methods and emerging synthetic approaches for producing these therapeutic compounds.
T4 · E29
31 ene 2025
46:36

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 27 Applying Six Sigma and Other Continuous Improvement Tools

This podcast episode explores the application of Six Sigma and continuous improvement tools in natural product manufacturing, particularly focusing on cannabis and psychedelic compounds. The discussion covers: - The DMAIC (Define, Measure, Analyze, Improve, Control) methodology and its practical applications - Quality by Design (QbD) principles and risk management frameworks - Real-world case studies, including improving terpene profile consistency in cannabis extracts and controlling impurities in pharmaceutical manufacturing The episode emphasizes how these quality control principles help manufacturers maintain consistency, safety, and efficacy in natural product manufacturing while meeting regulatory requirements.
T4 · E30
31 ene 2025
20:37

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 28 Putting It All Together – Case Study

This podcast episode explores the development process of bringing a psilocybin product to market using the Quality by Design (QbD) approach. The discussion covers critical quality attributes (CQAs), design of experiments (DOE), impurity testing, method validation, FDA submission requirements, and post-market surveillance. The hosts delve into important considerations like product safety, stability, and purity while also addressing broader societal concerns around accessibility, equity, and responsible use of psychedelic therapeutics.
T4 · E31
31 ene 2025
22:35

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 29 Future Developments and Controversies

This podcast episode explores future developments and ongoing debates in psychedelic medicine, covering key topics like personalized medicine approaches, whole plant reconstruction versus isolated compounds, and polypharmacy in psychedelic therapy. The discussion delves into emerging areas like non-psychotropic psychedelics, the role of the gut microbiome in psychedelic responses, and the development of designer psychedelics. The hosts examine both the promising potential and important challenges facing the field, emphasizing the need for careful research, ethical considerations, and responsible development of these therapies.
T4 · E32
31 ene 2025
29:02

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 30 Conclusions and Spiral Recap

In this concluding episode of a 30-day deep dive series on FDA drug development in cannabinoid and psychedelic spaces, the hosts reflect on their journey through regulatory frameworks, scientific concepts, and therapeutic applications. The discussion emphasizes the importance of spiral learning - building from fundamental concepts like FDA pathways and ICH guidelines to more complex topics in psychedelic science. They explore how these emerging therapies could transform mental healthcare, moving beyond symptom management to address root causes of suffering, while highlighting the critical balance between innovation and responsible development.
T4 · E33
31 ene 2025
35:39

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Non-Expert Quiz Show Podcast

This podcast episode takes the format of an educational quiz show that explores pharmaceutical drug development, with a focus on FDA guidelines and safety protocols. The hosts discuss important topics including nitrosamines and mutagenic impurities in medications, the four phases of clinical trials, and the role of psychedelics in treating mental health conditions and end-of-life care. The episode concludes with a discussion about the future of pharmaceuticals, including AI drug development and personalized medicine.
T4 · E34
31 ene 2025
14:39

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Expert Quiz Show Podcast

This episode is a quiz show-style deep dive into psychedelic drug development and manufacturing. The hosts explore three main topics: chemistry challenges including nitrosamines and palladium catalysis, clinical research methodology focusing on therapy manuals and study design, and manufacturing considerations with an emphasis on GMP (Good Manufacturing Practices) and quality control. The episode combines technical expertise with engaging dialogue to explain complex pharmaceutical concepts in an accessible way, concluding with reflections on the future potential of psychedelic therapies.
T4 · E35
31 ene 2025
15:19
Temporada 5

90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 1 The Universe of Human Receptors

Dive into the fascinating world of receptor pharmacology in this comprehensive introduction to how drugs interact with cellular receptors. Learn about the four major receptor families - GPCRs, RTKs, ion channels, and nuclear receptors - and discover how these molecular gatekeepers control everything from our senses to our heartbeat. Through engaging dialogue and clear analogies, explore the fundamental "lock and key" mechanism of drug-receptor interactions and understand how this knowledge drives modern medicine. Perfect for students, healthcare professionals, or anyone curious about how drugs work at the molecular level. This episode lays the foundation for understanding receptor pharmacology while highlighting real-world applications in treating conditions from allergies to heart disease.
T5 · E1
1 feb 2025
18:31

90 Day Deep Dive Podcast Series into the World of Human Receptor Pharmacology - Day 2 Key Terms & Concepts in Signal Transduction

In this enlightening episode of the receptor pharmacology series, dive into the fundamental language of drug-receptor interactions. Through engaging dialogue and clear analogies, experts break down essential concepts like receptors, ligands, agonists, and antagonists. Learn how drugs interact with cells through a fascinating "lock and key" mechanism, and discover the crucial differences between drug efficacy, potency, and selectivity. The episode demystifies complex phenomena like receptor desensitization and internalization, using everyday examples to explain how cells regulate their response to drugs. Perfect for students, healthcare professionals, and anyone curious about how medications work at the molecular level, this episode provides a solid foundation for understanding modern drug development and therapeutic approaches.
T5 · E2
1 feb 2025
36:56
16 de 26